An inexpensive test and single-dose treatment could help save the lives of nearly one million infants annually if pregnant women in low-income countries were offered rapid tests for syphilis, experts from the Global Congenital Syphilis Partnership said on Thursday, Reuters reports. “A team of researchers led by Rosanna Peeling and David Mabey at the [London School of Hygiene & Tropical Medicine (LSHTM)] found in a study due to be published soon that introducing rapid tests to increase access to syphilis screening was both feasible and cost effective,” the news agency writes.

According to experts, more than two million pregnant women are infected with syphilis each year, and more than half pass the infection on to their infants, Reuters notes, adding that in Africa, the disease causes nearly 400,000 stillbirths and infant deaths annually. The syphilis partnership includes the Bill & Melinda Gates Foundation, Save the Children, the WHO, the CDC and the LSHTM, according to the news agency (Kelland, 2/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.